Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
6 Fun Urban areas For Seniors To Travel - 2AfD faction in western Germany ousts councilman for firebrand speech
- 3South Carolina measles outbreak grows by nearly 100, spreads to North Carolina and Ohio
- 4When faith comes under fire: How Iran’s repression of religious minorities has increased
- 5Hilary Duff's husband responds to Ashley Tisdale's 'toxic' mom group claims: The drama, explained
- Viable Tips for Seniors to Purchase a Minimal expense Jeep Wrangler
- Ever Wonder What An EV Motorcycle Water Crossing Would Be Like? Here You Go
- How to sound like an astronaut as you follow the first human moon mission in more than half a century
- Is new Harry Styles music on the way? Fans think so, after a cryptic website and posters pop up.
- Vote in favor of Your #1 sort of pie
- Wedding trip Objections in the US
- Famous SUVs With Low Energy Utilization In 2024
- Jupiter and the moon take a sunset stroll on March 26. Here's how to see it
- The World's Dazzling Regular Miracles
